{"id":32290,"date":"2026-07-08T01:05:00","date_gmt":"2026-07-07T23:05:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=e89b25d94206e607b7998a64683b1ffb"},"modified":"2026-07-08T01:05:00","modified_gmt":"2026-07-07T23:05:00","slug":"abcellera-to-report-second-quarter-2026-financial-results-on-august-5-2026","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=32290","title":{"rendered":"AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026"},"content":{"rendered":"<p>VANCOUVER, British Columbia--(BUSINESS WIRE)--<a href=\"https:\/\/twitter.com\/search?q=%24ABCL&src=ctag\" >$ABCL<\/a>--<a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.abcellera.com&amp;esheet=54558433&amp;newsitemid=20260707637618&amp;lan=en-US&amp;anchor=AbCellera&amp;index=1&amp;md5=05dd9f64e36a75a6f454cbd763b80257\" rel=\"nofollow\" shape=\"rect\">AbCellera<\/a> (Nasdaq: ABCL) will announce its second quarter 2026 financial results on Wednesday, August 5, 2026, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260707637618\/en\/705128\/5\/AbCellera_Full_Colour_RGB_1.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260707637618\/en\/705128\/22\/AbCellera_Full_Colour_RGB_1.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260707637618\/en\/705128\/5\/AbCellera_Full_Colour_RGB_1.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260707637618\/en\/705128\/21\/AbCellera_Full_Colour_RGB_1.jpg\" \/><\/a><p>\nA live audio webcast of the earnings conference may be accessed through a link that will be posted on <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.abcellera.com%2Foverview%2Fdefault.aspx&amp;esheet=54558433&amp;newsitemid=20260707637618&amp;lan=en-US&amp;anchor=AbCellera%26%238217%3Bs+Investor+Relations+website&amp;index=2&amp;md5=2a15aac5000bd3a1ae7b8b978f6d6f47\" rel=\"nofollow\" shape=\"rect\">AbCellera\u2019s Investor Relations website<\/a>. A replay will be available through the same link following the conference call.<\/p><p>\n<b>About AbCellera Biologics Inc.<\/b><\/p><p>\n<a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.abcellera.com&amp;esheet=54558433&amp;newsitemid=20260707637618&amp;lan=en-US&amp;anchor=AbCellera&amp;index=3&amp;md5=d16d447cc53442b5c06396e611561b61\" rel=\"nofollow\" shape=\"rect\">AbCellera<\/a> (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody-based medicines in the areas of endocrinology, women\u2019s health, immunology, oncology, and more. For more information, please visit <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.abcellera.com&amp;esheet=54558433&amp;newsitemid=20260707637618&amp;lan=en-US&amp;anchor=www.abcellera.com&amp;index=4&amp;md5=f28ef71717bd47a808ac72116ce4475c\" rel=\"nofollow\" shape=\"rect\">www.abcellera.com<\/a>.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\n<b>Inquiries\n<br\/>\n<\/b><br\/>Media: Tiffany Chiu; <a  href=\"mailto:media@abcellera.com\" rel=\"nofollow\" shape=\"rect\">media@abcellera.com<\/a>, +1(236)521-6774\n<br\/>Partnering: Murray McCutcheon, Ph.D.; <a  href=\"mailto:partnering@abcellera.com\" rel=\"nofollow\" shape=\"rect\">partnering@abcellera.com<\/a>, +1(604)559-9005\n<br\/>Investor Relations: Peter Ahn; <a  href=\"mailto:ir@abcellera.com\" rel=\"nofollow\" shape=\"rect\">ir@abcellera.com<\/a>, +1(778)729-9116<\/p>","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, British Columbia&#8211;(BUSINESS WIRE)&#8211;$ABCL&#8211;AbCellera (Nasdaq: ABCL) will announce its second quarter 2026 financial results on Wednesday, August 5, 2026, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) &#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-32290","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=32290"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32290\/revisions"}],"predecessor-version":[{"id":32291,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32290\/revisions\/32291"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=32290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=32290"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=32290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}